The removal of a major hippocampal afferent system, the glutamatergic fibers from the entorhinal cortex, results in transneuronal changes in postsynaptic inhibitory neurons using y-aminobutyric acid (GABA) as a neurotransmitter. This study shows that these transneuronal alterations are reduced by the selective N-methyl-D-aspartate (NMDA) receptor antagonist (+)-MK-801. Thus, systemic injection of (+)-MK-801 prior to and after entorhinal lesion abolishes the retraction of distal dendrites from the termination zones of degenerating entorhinal fibers and reduces the swelling oftheir distal segments. Also, entorhinal lesion results in the appearance of c-os protein-like immunoreactivit in hippocampal neurons and glial cells, which again is blocked by (+)-MK-801 administration. These data suggest that NMDA receptormediated neurotoxicity due to postlesional glutamate elevation results in early gene expression and in transneuronal dendritic changes. Similar processes may play a role in Alzheimer's dsease, since there is a severe degeneration of the glutamatergic entorhino-hippocampal projection in this neurodegenerative disorder.
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Glutamate neurotoxicity has been studied in a variety of experimental in vitro model systems (1) (2) (3) (4) , and the involvement of excitatory amino acids in acute (5, 6) and chronic neuronal degeneration (7) (8) (9) has been demonstrated. N-Methyl-D-aspartate (NMDA) receptor-mediated processes are known to play a key role in these neurotoxic glutamate effects (5, 6) . After entorhinal cortex lesion (10) , we have demonstrated transneuronal alterations of peripheral dendrites of hippocampal neurons using -aminobutyric acid (GABA) as a transmitter. The majority of the perforant path fibers arising from the entorhinal cortex and terminating in the hippocampus and fascia dentata is known to use the excitatory amino acid glutamate as a transmitter (11) . Elevation of extracellular concentration of glutamate in the hippocampus in the course of neuronal degeneration has recently been demonstrated by intracerebral microdialysis (12) . To study the involvement of a postlesional pathological glutamate release leading to NMDA receptor-mediated neurotoxicity, we have studied the effects of the selective NMDA receptor antagonist (+)-MK-801 (13) on transneuronal dendritic changes.
Recent studies have shown that the expression of "immediate early genes" such as c-fos is related to NMDA receptormediated neurodegeneration under pathological conditions (14, 15) . Thus, we analyzed the effects of MK-801 on the expression of c-fos protein in the same experimental paradigm. The activation of the immediate early gene c-fos can be demonstrated on the level of protein synthesis by using antibodies to c-fos protein (15) .
In our experimental paradigm, neurons are selectively labeled with antibodies against the calcium-binding protein parvalbumin (10, 16) . These cells form a subpopulation of hippocampal GABAergic cells and are stained in a Golgi-like manner (17)-i.e., their entire dendritic arbor can be observed extending into the termination zones of the entorhinal fibers. This allows for an analysis of distal dendritic changes. Previous studies have demonstrated that all parvalbuminimmunoreactive neurons in the hippocampus and fascia dentata contain the inhibitory neurotransmitter GABA (17) and that the entorhinal fibers, in addition to contacting principal neurons (18) , establish synapses with parvalbuminimmunoreactive cells (19) . Thus, our in vivo model enables us to study transneuronal changes in identified postsynaptic elements after entorhinal lesion. (h) next to the granule cell layer offascia dentata (g) and CA1 pyramidal cell layer of hippocampus proper (p), respectively. Their dendrites run through the molecular layer (ml) and stratum radiatum (r) and stratum lacunosum-moleculare (Im), respectively, and approach the hippocampal fissure (th). In stratum lacunosum-moleculare and in the outer molecular layer next to the hippocampal fissure, the perforant path fibers (arrows) from the entorhinal cortex terminate. The small framed area 2 corresponds to the region shown in the micrographs of Fig. 2 . Large framed area 3 corresponds to the region shown in the micrographs of Fig. 3 a-c.
MATERIALS AND METHODS
on both sides of the hippocampal fissure by using a drawing tube.
Sixteen animals (see above) were used for the second set of experiments. Thirty minutes prior to unilateral lesion of the entorhinal cortex, (+)-MK-801 was administered (3 mg/kg i.p.) as an aqueous solution. Five hours after the operation, the animals were sacrificed. Anesthesia, lesion, fixation, and tissue preparation were the same as described above. This time a monoclonal mouse anti-Parv antiserum (16) 
RESULTS
Forty-eight hours after lesion of the entorhinal cortex, the distal dendrites of parvalbumin-positive neurons have retracted from the termination sites of the degenerating entorhinal fibers close to the hippocampal fissure (Figs. 1 and  2b ) (10) . Their dendritic tips in stratum lacunosummoleculare of the hippocampus proper and in the outer molecular layer of the fascia dentata displayed large varicose swellings (Fig. 2b) . Sections from nonoperated animals ( Fig.  2a) and from animals that had received a (+)-MK-801 treatment prior to and every 12 hr after entorhinal lesion (Fig. 2c) showed smooth dendrites of parvalbumin-immunoreactive hippocampal neurons traversing the stratum lacunosummoleculare of the hippocampus proper and dentate neurons traversing the outer molecular layer of the fascia dentata, meeting each other at the hippocampal fissure. In comparison with lesioned animals, the number of swellings on distal tips of parvalbumin-positive dendrites was reduced by 78% ± 3 on the dentate and by 64% ± 4 on the hippocampal side of the fissure when the lesion was accompanied by a (+)-MK-801 treatment ( Fig. 2 b and c; n = 4). Immunoreactivity for c-fos protein in hippocampal neurons and glial cells 5 hr after entorhinal lesion (Fig. 3b) can be blocked almost completely by (+)-MK-801 treatment prior to operation (Fig. 3c) , thus emulating the absence of immunoreactivity as observed in nonoperated animals (Fig. 3a) . In lesioned but non-(+)-MK-801-treated animals, neurons in the hilus showed pronounced c-fos protein-like immunoreactivity (Fig. 3b) , including parvalbumin-containing cells as revealed by double labeling studies (Fig. 3d) .
DISCUSSION
One interpretation of these data is that transneuronal alteration after entorhinal cortex lesion results from postlesional glutamate elevation (12) , leading to NMDA receptormediated c-fos expression (20, 21 ). This in turn may activate .> lesion genes regulating cytoskeletal remodeling of postsynaptic dendrites. NMDA receptor activation may thus cause the acute cytopathology occurring after status epilepticus, cerebral ischemia, and trauma (5, 6, 22) . The electrolytic lesion of the entorhinal cortex as applied in the present experiments may mimic some of the pathological mechanisms of status epilepticus (23, 24) by resulting in an increased glutamate release from perforant path terminals in the fascia dentata and hippocampus. However, the persisting dendritic retraction of parvalbumin-containing neurons after entorhinal lesion (10) cannot be explained by glutamate neurotoxicity alone. Terminal degeneration of entorhinal fibers may play a major role in these postsynaptic dendritic alterations. It appears that the maintenance of peripheral dendritic segments of parvalbumin-containing neurons requires the specific afferent innervation from the entorhinal cortex (10) .
The increase in intracellular calcium, which is induced by NMDA receptor activation, has been related to long-term changes in neuronal excitability, neuronal development, and cell death, probably mediated by changes in gene expression (13, 20, 21, 25) . Administration of NMDA receptor antagonists such as (+)-MK-801 is effective in protecting neurons from glutamate-induced degeneration (26) and from traumatic degeneration and blocks the activation of the immediate early gene c-fos (1-3, 13) . The reduction of transneuronal changes after entorhinal lesion by (+)-MK-801 may be due to the blockade of NMDA receptor-induced calcium influx, which otherwise would lead to c-fos expression and to cytoskeletal changes (25) . In a previous study we showed that these cytoskeletal changes result in persisting dendritic alterations (10) . The present study demonstrates the involvement of NMDA receptors in initial stages of this process. Activation of mRNAs encoding for cytoskeletal proteins such as actin and tubulin has been demonstrated for the rat fascia dentata after entorhinal lesion (27) . It may be of interest that persisting dendritic retraction after entorhinal lesion has been shown exclusively for parvalbumincontaining cells (10) and not for dentate granule cells (28) . Granule cells lack this calcium-binding protein (17) . Our results suggest a pronounced activation of c-fos in parvalbumin-containing neurons (Fig. 3 b and d) . The role of the calcium-binding protein parvalbumin in controlling postlesional NMDA receptor-induced calcium influx as well as long-term effects of the MK-801 treatment remain to be elucidated.
The glutamatergic projection from the entorhinal cortex to the hippocampus is among the first pathways to be severely affected in Alzheimer disease (29) . In this neurodegenerative disorder and after entorhinal lesions in rats, an elevation of a pathological glycoprotein in the hippocampus has been Neurobiology: Nitsch (30) . It is of interest that Alzheimer-type cytopathological changes have been induced in cultured human neurons by glutamate exposure (31, 32) and have been observed in a chronic neurological syndrome linked to dietary consumption of excitatory amino acid toxins (Guam disease) (7) . The data of the present study suggest that primary neuropathological degeneration of entorhinal projection neurons in Alzheimer disease (29) may result in secondary NMDA receptormediated dendritic alterations in GABAergic hippocampal neurons. Such subtle dendritic changes have to be taken into consideration, since parvalbumin-containing neurons are reported to survive in this disease (33) .
